Last €47.07 EUR
Change Today +0.84 / 1.82%
Volume 0.0
8AK On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:52 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kathryn L. Biberstein

Chief Legal Officer, Chief Compliance Officer, Senior Vice President of Government Relations & Public Policy and Secretary, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

55$2,113,308
As of Fiscal Year 2013

Background*

Ms. Kathryn L. Biberstein, also known as Kathy has been Chief Legal Officer and Chief Compliance Officer of Alkermes plc since September 2011 and March 2003; its Secretary since June 2004 and serves as its Senior Vice President of Government Relations & Public Policy. She served as a General Counsel of Alkermes plc from March 2003 to September 2011. She served as a Vice President of Alkermes plc from March 2003 to May 22, 2007. She served as a Senior Vice President of ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Kettering University
JD
The University of Michigan Law School

Other Affiliations*

Annual Compensation*

Salary$435,458
Total Annual Compensation$435,458

Stock Options*

Restricted Stock Awards$297,900
All Other Compensation$12,750
Exercised Options72,192
Exercised Options Value$1,036,870
Exercisable Options467,808
Exercisable Options Value$12,572,645
Unexercisable Options241,625
Unexercisable Options Value$4,478,245
Total Value of Options$18,087,760
Total Number of Options781,625

Total Compensation*

Total Annual Cash Compensation$848,208
Total Short Term Compensation$435,458
Other Long Term Compensation$310,650
Total Calculated Compensation$2,113,308
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €47.07 EUR +0.84

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.